首页|期刊导航|辽宁中医药大学学报|基于化学蛋白质组学技术揭示雷公藤甲素抑制肺周细胞衰老的作用机制

基于化学蛋白质组学技术揭示雷公藤甲素抑制肺周细胞衰老的作用机制OA

Analysis on the Mechanism of Triptolide Inhibiting Peripulmonary Cell Senescence Revealed Based on Chemical Proteomics Technology

中文摘要英文摘要

目的 借助化学蛋白质组学技术寻找雷公藤甲素(triptolide,TPL)治疗肺纤维化(idiopathic pulmonary fibrosis,IPF)的蛋白靶点,对其药理作用的分子机制展开探究,进而为新药开发以及药物在临床上的应用给予实验方面的参考.方法 通过细胞培养、给药,采用CCK-8方法检测雷公藤甲素对小鼠肺微血管周细胞(SNPM-M175)增殖的影响.借助流式细胞术检测雷公藤甲素对肺微血管周细胞凋亡情况的影响.利用点击化学反应和凝胶电泳技术检测雷公藤甲素能否占据雷公藤甲素探针(TPL-p)在肺微血管周细胞内的蛋白结合位点.利用串联质谱标签(TMT)结合液相色谱-串联质谱(LC-MS/MS)技术,对雷公藤甲素抗IPF 的关键靶点进行定量分析,并且结合生物信息学分析探究雷公藤甲素治疗肺纤维化可信度较高的靶标蛋白,并对其进行生物信息学分析,明确其作用靶点.采用LC-MS/MS技术分析雷公藤甲素给药组与模型组小鼠肺纤维化组织的差异蛋白表达谱.Western Blot法测定肺组织中转化生长因子-β1(TGF-β1)及Smad3蛋白表达.结果 肺成纤维细胞增殖的抑制关键在于诱导肺微血管周细胞凋亡,检测到雷公藤甲素对肺微血管周细胞凋亡有影响.结果显示,对照组、TPL 20 μmol/L组、TPL 10 μmol/L组、TPL 5 μmol/L组肺微血管周细胞凋亡率分别为5.82%、8.39%、21.46%、58.37%.TPL 20 μmol/L给药能有效抑制肺微血管周细胞衰老.在给药雷公藤甲素12 h后进行活性氧(ROS)检测,结果显示相比于对照组,细胞内ROS水平在TPL 5 μmol/L组、TPL 10 μmol/L组、TPL 20 μmol/L组均有显著提升(P<0.001).TPL-p探针所占据肺微血管周细胞中蛋白的半胱氨酸残基结合位点能被雷公藤甲素竞争占据.与对照组比较,TPL 20 μmol/L组、TPL 10 μmol/L组、TPL 5 μmol/L组小鼠肺组织中TGF-β1和Smad3蛋白表达显著增加(P<0.01);与TPL 5 μmol/L组比较,TPL 20 μmol/L组可显著降低TGF-β1蛋白的表达(P<0.05),且显著下调肺组织中Smad3蛋白的表达(P<0.05).结论 雷公藤甲素通过靶向TGF-β1和Smad3抑制肺微血管周细胞衰老,可能为抗肺纤维化提供新的策略.

Objective To identify the protein targets of triptolide(TPL)in the treatment of idiopathic pulmonary fibrosis(IPF)using chemical proteomics technology,explore the molecular mechanism of its pharmacological effects,and thereby provide experimental references for the development of new drugs and the clinical application of TPL.Methods Mouse pulmonary microvascular pericytes(SNPM-M175)were tested for the effect of pericyte proliferation in pulmonary microvessels by CCK-8.The effect of TPL on apoptosis in the help of flow cytometry.Whether TPL can occupy the protein binding site of the triptolide(TPL-p)probe in pulmonary microvascular pericytes is tested using click chemical reaction and gel electrophoresis.Using tandem mass spectrometry tag(TMT)combined with liquid chromatography-tandem mass spectrometry(LC-MS/MS)technology,the key targets of TPL anti-IPF,and the target proteins of TPL in the treatment of pulmonary fibrosis,and the bioinformatics analysis to identify the target.The technique was used to analyze the differential protein expression profiles of lung fibrosis tissues between the TPL administration group and the model group mice by LC-MS/MS.The expressions of TGF-β1 and Smad3 proteins in lung tissues was determined by Western Blot.Results The key to the inhibition of lung fibroblast proliferation is the induction of apoptosis of pulmonary microvascular peripheral cells.The results showed that the apoptosis rate of the control,TPL 20 μmol/L,TPL 10 μmol/L,and TPL 5 μmol/L groups were 5.82%,8.39%,21.46%,and 58.37%,respectively.TPL 20 μmol/L drug administration could effectively inhibit pulmonary microvascular periimeter senescence.After 12 h,ROS were tested,and the results showed that intracellular ROS levels were significantly increased in the TPL 5 μmol/L,TPL 10 μmol/L and TPL 20 μmol/L groups compared with the control group(P<0.001).The cysteine residue binding site of the protein in lung microvascular pericytes occupied by the TPL-p probe could be competed out by triptolide.Compared with the control group,the expressions of TGF-β1 and Smad3 proteins in lung tissues of the TPL 20 μmol/L group,TPL 10 μmol/L group and TPL 5 μmol/L group were significantly increased(P<0.01).Compared with the TPL 5 μmol/L group,the expression of TGF-β1 protein in the TPL 20 μmol/L group was significantly decreased(P<0.05),and the expression of Smad3 protein in lung tissues was significantly down-regulated(P<0.05).Conclusion By targeting TGF-β1 and Smad3,it inhibited pulmonary microvascular pericyte senescence and may provide a new strategy against pulmonary fibrosis.

陈宏;宋倩男;齐鑫;管欣悦;陈群;隋博文

黑龙江中医药大学附属第一医院,黑龙江 哈尔滨 150040黑龙江中医药大学,黑龙江 哈尔滨 150040黑龙江中医药大学附属第一医院,黑龙江 哈尔滨 150040黑龙江中医药大学,黑龙江 哈尔滨 150040哈尔滨市阿城区人民医院,黑龙江 哈尔滨 150300黑龙江中医药大学附属第一医院,黑龙江 哈尔滨 150040

医药卫生

化学蛋白质组学雷公藤甲素肺纤维化肺周细胞衰老作用机制

chemical proteomicstriptolidepulmonary fibrosisperipulmonary cellsagingaction mechanism

《辽宁中医药大学学报》 2026 (5)

1-6,6

黑龙江省自然科学基金项目(LH2023H074)中国博士后科学基金第13批特别资助项目(2020T130178)黑龙江省卫生健康委科研课题(20230202040115)

10.13194/j.issn.1673-842X.2026.05.001

评论